155 related articles for article (PubMed ID: 8851178)
1. Somatostatin receptors in the developing rat brain.
Thoss VS; Duc D; Hoyer D
Eur J Pharmacol; 1996 Feb; 297(1-2):145-55. PubMed ID: 8851178
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
Thoss VS; Piwko C; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors.
Piwko C; Thoss VS; Schüpbach E; Kummer J; Langenegger D; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):161-7. PubMed ID: 9050007
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
Thoss VS; Piwko C; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
[TBL] [Abstract][Full Text] [Related]
5. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei.
Bucharles C; Vaudry H; Leroux P
Eur J Pharmacol; 1994 Dec; 271(1):79-86. PubMed ID: 7698215
[TBL] [Abstract][Full Text] [Related]
7. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
[TBL] [Abstract][Full Text] [Related]
8. Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis.
Piwko C; Thoss VS; Samanin R; Hoyer D; Vezzani A
Neuroscience; 1996 Dec; 75(3):857-68. PubMed ID: 8951879
[TBL] [Abstract][Full Text] [Related]
9. Localization and pharmacological characterization of somatostatin recognition sites in the human cerebellum.
Piwko C; Thoss VS; Probst A; Hoyer D
Neuropharmacology; 1996 Jun; 35(6):713-23. PubMed ID: 8887980
[TBL] [Abstract][Full Text] [Related]
10. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Siehler S; Seuwen K; Hoyer D
Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
Siehler S; Zupanc GK; Seuwen K; Hoyer D
Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats.
Pérez J; Vezzani A; Civenni G; Tutka P; Rizzi M; Schüpbach E; Hoyer D
Neuroscience; 1995 Apr; 65(4):1087-97. PubMed ID: 7617164
[TBL] [Abstract][Full Text] [Related]
14. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors.
Schoeffter P; Pérez J; Langenegger D; Schüpbach E; Bobirnac I; Lübbert H; Bruns C; Hoyer D
Eur J Pharmacol; 1995 Mar; 289(1):163-73. PubMed ID: 7781707
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
[TBL] [Abstract][Full Text] [Related]
16. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of expression and physiological effects of sst1 and sst2 receptor subtypes in mouse hypothalamic neurons and astrocytes in culture.
Viollet C; Lanneau C; Faivre-Bauman A; Zhang J; Djordjijevic D; Loudes C; Gardette R; Kordon C; Epelbaum J
J Neurochem; 1997 Jun; 68(6):2273-80. PubMed ID: 9166719
[TBL] [Abstract][Full Text] [Related]
18. Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum.
Piwko C; Thoss VS; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):607-13. PubMed ID: 9053731
[TBL] [Abstract][Full Text] [Related]
19. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
Raynor K; Reisine T
J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690
[TBL] [Abstract][Full Text] [Related]
20. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
Hadcock JR; Strnad J; Eppler CM
Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
